ロード中...
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
SIMPLE SUMMARY: Despite the adoption of aggressive, multimodal treatment schedules, the cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 years. The most relevant problem preventing improvement in HGOS prognosis is drug resistance. Therefore, validated novel b...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8228414/ https://ncbi.nlm.nih.gov/pubmed/34207685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122878 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|